Dopamine and serotonin cotransmission filters striatonigral synaptic activity via 5-HT1B receptor activation
Science Advances · 2025
DOI: 10.1126/sciadv.adx4577 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Maya Molinari und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Receptor, Serotonin, 5-HT1B, Dopamine, Serotonin, Substantia Nigra. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIMH NIH HHS.
Abstract (Originalsprache)
The substantia nigra pars reticulata (SNr), a key basal ganglia output nucleus, is modulated by dopamine (DA) believed to be released locally from midbrain DA neurons. Although DA has been proposed to regulate γ-aminobutyric acid (GABA) release from medium spiny neuron (MSN) terminals via presynaptic D1 receptors, the precise mechanisms remain unclear. Using presynaptic optical recordings of synaptic vesicle fusion, calcium influx in D1-MSN synapses together with postsynaptic patch-clamp recordings from SNr neurons, we found that DA inhibits D1-MSN GABA release in a frequency-dependent manner. Unexpectedly, this effect was independent of DA receptors and instead required 5-HT1B receptor activation. Using two-photon serotonin biosensor imaging in slices and fiber photometry in vivo, we demonstrate that DA enhances extracellular serotonin in the SNr via inhibition of serotonin reuptake. Our results suggest that serotonin mediates DAergic control of basal ganglia output and contributes to the therapeutic actions of dopaminergic medications for Parkinson’s disease and psychostimulant-related disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
- Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
- Department of Psychiatry, Neurology, Pharmacology, Columbia University Irving, Medical Center, and Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.
ORCID-Profile: Maya Molinari, Alina Aaltonen, David Sulzer, Emanuela Santini, Anders Borgkvist
Förderung
- NIDA NIH HHS
- NIMH NIH HHS
Zitieren
APA
Molinari, M., Aaltonen, A., Lieberman, O. J., Sulzer, D., Santini, E., & Borgkvist, A. (2025). Dopamine and serotonin cotransmission filters striatonigral synaptic activity via 5-HT1B receptor activation. Science Advances. https://doi.org/10.1126/sciadv.adx4577
Vancouver
Molinari M, Aaltonen A, Lieberman OJ, Sulzer D, Santini E, Borgkvist A. Dopamine and serotonin cotransmission filters striatonigral synaptic activity via 5-HT1B receptor activation. Science Advances. 2025. doi:10.1126/sciadv.adx4577
BibTeX
@article{Molinari2025,
author = {Molinari, Maya and Aaltonen, Alina and Lieberman, Ori J and Sulzer, David and Santini, Emanuela and Borgkvist, Anders},
title = {Dopamine and serotonin cotransmission filters striatonigral synaptic activity via 5-HT1B receptor activation},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adx4577}
}
EUVIMED